WHO SHOULD TAKE THIS COURSE?
These courses are suitable for persons conducting clinical trials of drugs and devices primarily in Canada. Many pharmaceutical companies have accepted CITI courses in lieu of their own in-house training (e.g., Pfizer, Abbott, Novartis, BMS, Astra- Zeneca, Bayer, Lilly, J&J, Roche, Sanofi-Aventis, Pharmanet and Amgen). The GCP Basic and Refresher courses meet TranCelerate criteria for ICH GCP training for investigator site personnel. This means that completion of the CITI-Canada course eliminates the need for completion of another GCP course often requested by a particular company and thus reduces duplication.